Neurology Consultant spoke with Majid Fotuhi, MD, PhD, about available data on short-term and long-term neurological complications of COVID-19, as well as the “NeuroCovid” classification scheme he and his...
Neurology Consultant spoke with Majid Fotuhi, MD, PhD, about available data on short-term and long-term neurological complications of COVID-19, as well as the “NeuroCovid” classification scheme he and his...
Neurology Consultant spoke with Majid Fotuhi, MD, PhD, about available data on short-term and long-term neurological complications of COVID-19, as well as the “NeuroCovid” classification scheme he and his...
Neurology Consultant spoke with Majid Fotuhi, MD, PhD, about available data on short-term and long-term neurological complications of COVID-19, as well as the “NeuroCovid” classification scheme he and his...
Neurology Consultant spoke with Majid Fotuhi, MD, PhD, about available data on short-term and long-term neurological complications of COVID-19, as well as the “NeuroCovid” classification scheme he and his...
For Pride Month, Nutrition411 spoke with Whitney Linsenmeyer, PhD, RD, LD, spokesperson for the Academy of Nutrition and Dietetics, about important aspects of providing nutrition care to transgender...
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
